Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer

European Urology

Volumn 59, Issue 6, 2011, Pages 1026-1031

  Zlotta, Alexandre R ^a,b,f   Roumeguere, Thierry ^c   Kuk, Cynthia ^b   Alkhateeb, Sultan ^b   Rorive, Sandrine ^c   Lemy, Anne ^c   Van Der Kwast, Theodorus H ^a   Fleshner, Neil E ^b   Jewett, Michael A S ^b   Finelli, Antonio ^b   Schulman, Claude ^c   Lotan, Yair ^d   Shariat, Shahrokh F ^e   Nortier, Joelle ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bladder cancer; Muscle invasion; Screening; Stage

Indexed keywords

GEMCITABINE; INDUSTRIAL CHEMICAL; MITOMYCIN C;

ADVANCED CANCER; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; BLADDER MUSCLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; MALE; MUSCLE TUMOR; NEPHROURETERECTOMY; NONMUSCLE INVASIVE BLADDER CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; TRANSITIONAL CELL CARCINOMA;

ANTI-OBESITY AGENTS; ARISTOLOCHIC ACIDS; ATROPHY; BIOPSY; CYSTOSCOPY; DRUGS, CHINESE HERBAL; EARLY DETECTION OF CANCER; FEMALE; FIBROSIS; HUMANS; KIDNEY DISEASES; MALE; MASS SCREENING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 79955601707     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.03.027     Document Type: Article

References (19)

1. M.F. Botteman, C.L. Pashos, A. Redaelli, B. Laskin, and R. Hauser The health economics of bladder cancer: a comprehensive review of the published literature Pharmacoeconomics 21 2003 1315 1330 (Pubitemid 38041357)
2. B.W.G. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
3. National Cancer Institute. SEER Cancer Statistics Review 1975-2007. Surveillance Epidemiology and End Results Web site. http://seer.cancer.gov/csr/ 1975-2007/results-merged/sect-27-urinary-bladder.pdf.
4. E.M. Messing, R. Madeb, and T. Young Long-term outcome of hematuria home screening for bladder cancer in men Cancer 107 2006 2173 2179 (Pubitemid 44665651)
5. D. Baris, M.R. Karagas, and C. Verrill A case-control study of smoking and bladder cancer risk: emergent patterns over time J Natl Cancer Inst 101 2009 1553 1561
6. F.D. Debelle, J.L. Vanherweghem, and J.L. Nortier Aristolochic acid nephropathy: a worldwide problem Kidney Int 74 2008 158 169 (Pubitemid 351915079)
7. J.L. Nortier, M.C. Martinez, and H.H. Schmeiser Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med 342 2000 1686 1692 (Pubitemid 30354515)
8. A. Lemy, K.M. Wissing, and S. Rorive Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up Am J Kidney Dis 51 2008 471 477 (Pubitemid 351273477)
9. J.P. Cosyns, M. Jadoul, and J.P. Squifflet Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 45 1994 1680 1688 (Pubitemid 24207504)
10. J.P. Cosyns, M. Jadoul, J.P. Squifflet, P.J. Van Cangh, and C. van Ypersele de Strihou Urothelial malignancy in nephropathy due to Chinese herbs Lancet 344 1994 188 (Pubitemid 24218887)
11. US Department of Health and Human Services. Screening for bladder cancer in adults recommendation. US Preventive Services Task Force Web site. http://www.uspreventiveservicestaskforce.org/uspstf/uspsblad.htm.
12. Home page. Canadian Task Force on Preventive Health Care Web site. http://www.canadiantaskforce.ca/index.html.
13. R. Chou, and T. Dana Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force Ann Intern Med 153 2010 461 468
14. M.P. Mayfield, and P. Whelan Bladder tumours detected on screening: results at 7 years Br J Urol 82 1998 825 828 (Pubitemid 28556729)
15. Y. Lotan, K. Elias, and R.S. Svatek Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker J Urol 182 2009 52 57
16. J.L. Vanherweghem, C. Tielemans, J. Simon, and M. Depierreux Chinese herbs nephropathy and renal pelvic carcinoma Nephrol Dial Transplant 10 1995 270 273
17. J. Palou, O. Angerri, and J. Segarra Intravesical bacillus Calmette-Guérin for the treatment of superficial bladder cancer in renal transplant patients Transplantation 76 2003 1514 1516 (Pubitemid 37467704)
18. D. Volanis, T. Kadiyska, A. Galanis, D. Delakas, S. Logotheti, and V. Zoumpourlis Environmental factors and genetic susceptibility promote urinary bladder cancer Toxicology Lett 193 2010 131 137
19. B. Einollahi, N. Simforoosh, and M. Lessan-Pezeshki Genitourinary tumor following kidney transplantation: a multicenter study Transplant Proc 41 2009 2848 2849